Monday, November 16, 2026 | 12:11 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 2 - Q3 Results

Zydus Wellness zooms 16% on huge volumes; up 4th day in weak market

A combined 27.84 million equity shares representing 8.75 per cent of total equity of the Zydus Wellness changed hands on the NSE and BSE till 01:37 PM on Friday.

Zydus Wellness zooms 16% on huge volumes; up 4th day in weak market
Updated On : 13 Mar 2026 | 2:37 PM IST

Adani Total Gas soars 18% on heavy volumes in weak market; here's why

The average trading volumes on the ATGL counter jumped over 20-fold with a combined 16.44 million equity shares changing hands on the NSE and BSE till 01:16 PM.

Adani Total Gas soars 18% on heavy volumes in weak market; here's why
Updated On : 11 Mar 2026 | 1:45 PM IST

Sun Pharma up 5% in 1 week, nears 52-week high; what's driving this stock?

Sun Pharma is transitioning its US business from low-margin generics to high-value specialty and innovative therapies.

Sun Pharma up 5% in 1 week, nears 52-week high; what's driving this stock?
Updated On : 11 Mar 2026 | 10:10 AM IST

TCS stock at lowest level since October 2020, tanks 17% in 1 month

Thus far in the calendar year 2026, TCS's market price plunged 23 per cent, as against 7.4 per cent decline in Nifty 50, data shows. The NIfty IT index lost over 1 per cent in trade on Tuesday.

TCS stock at lowest level since October 2020, tanks 17% in 1 month
Updated On : 10 Mar 2026 | 2:15 PM IST

Natco rallies 5%, nears 52-week high; what's driving pharma stock?

In the past four trading days, the stock price of Natco Pharma has surged 10 per cent after the company announced the launch of Pomalidomide Capsules (generic of Pomalyst) in the US market.

Natco rallies 5%, nears 52-week high; what's driving pharma stock?
Updated On : 10 Mar 2026 | 10:10 AM IST

Emcure Pharmaceuticals soars 9% in weak market on huge volumes

Emcure Pharmaceuticals stock was quoting close to its 52-week high of ₹1,585.50 on Monday, and has surged up to 62% in the last one year.

Emcure Pharmaceuticals soars 9% in weak market on huge volumes
Updated On : 09 Mar 2026 | 3:06 PM IST

Meesho freezes at 10% lower circuit, hits record low; here's why

Meesho said the Assessment Order along with the Demand Notice does not have any major adverse impact on the company's financial position, operations, or other activities.

Meesho freezes at 10% lower circuit, hits record low; here's why
Updated On : 09 Mar 2026 | 12:42 PM IST

Kwality Wall's tanks 8% to its all-time low as Q3 net loss widens QoQ

On a quarter-on-quarter (Q-o-Q) basis, the company's net loss widened to ₹178.38 crore, as compared to a loss of ₹100.16 crore in Q2FY26

Kwality Wall's tanks 8% to its all-time low as Q3 net loss widens QoQ
Updated On : 09 Mar 2026 | 10:19 AM IST

Astral surges 16% in 1 month, stock hits 52-week high in weak market

The management has maintained a double-digit volume growth forecast for Q4FY26 and FY27E, targeting 17-18 per cent EBITDA margin for Plumbing division and 12 -13 per cent for Paints & Adhesives.

Astral surges 16% in 1 month, stock hits 52-week high in weak market
Updated On : 06 Mar 2026 | 1:36 PM IST

Belrise Industries zooms 101% in 9 months; hits record high in weak market

Crisil Ratings believes that the Belrise group will maintain its strong position in the auto components industry backed by its established customer relationships and a diversified product portfolio.

Belrise Industries zooms 101% in 9 months; hits record high in weak market
Updated On : 06 Mar 2026 | 11:08 AM IST

Fractal Q3 profit rises 10.5% on strong healthcare and BFS growth

Fractal Analytics reported a 10.5% rise in Q3 profit to ₹102.6 crore, with revenue up 21% year-on-year as healthcare, life sciences and BFS demand lifted its first post-listing results

Fractal Q3 profit rises 10.5% on strong healthcare and BFS growth
Updated On : 05 Mar 2026 | 10:58 PM IST

Bharat Electronics rallies 4%; why defence stock hit new high?

Thus far in the calendar year 2026, BEL has outperformed the market by surging 16%, as compared to 6.6% decline in the BSE Sensex.

Bharat Electronics rallies 4%; why defence stock hit new high?
Updated On : 05 Mar 2026 | 11:59 AM IST

Acutaas zooms 100% in 8 months; what's driving speciality chemicals stock?

Acutaas Chemicals management has revised revenue guidance upwards from 25 per cent to around 30 per cent growth for FY26.

Acutaas zooms 100% in 8 months; what's driving speciality chemicals stock?
Updated On : 05 Mar 2026 | 11:28 AM IST

Lupin rallies 12% thus far in CY26, outperforms market; here's why

In the past one month, Lupin has outperformed the market by soaring 6 per cent, as against 4.5 per cent decline in the BSE Sensex.

Lupin rallies 12% thus far in CY26, outperforms market; here's why
Updated On : 05 Mar 2026 | 10:20 AM IST

Sai Life hits record high in weak market; rebounds 5% from day's low

Supported by solid demand, disciplined execution, and capex programs progressing as planned, Sai Life management remains confident in sustaining positive growth momentum.

Sai Life hits record high in weak market; rebounds 5% from day's low
Updated On : 04 Mar 2026 | 3:20 PM IST

BSE Realty index hits 52-week low; DLF, Lodha, Sobha dip up to 4%

In the past one month, the realty index has tanked 10 per cent, as against 6 per cent fall in the BSE Sensex.

BSE Realty index hits 52-week low; DLF, Lodha, Sobha dip up to 4%
Updated On : 04 Mar 2026 | 10:46 AM IST

Sentiment shift: Earnings upgrade to downgrade ratio improved after Q3

There are hopes of a turnaround in overall corporate earnings after six quarters of single digit growth

Sentiment shift: Earnings upgrade to downgrade ratio improved after Q3
Updated On : 03 Mar 2026 | 11:51 PM IST

Square Yards Q3FY26 revenue rises 47%, gross profit up 23% at ₹120 crore

Proptech firm Square Yards posted a 47 per cent year-on-year rise in Q3FY26 revenue, with Ebitda margin at 8 per cent and improved margins across business segments

Square Yards Q3FY26 revenue rises 47%, gross profit up 23% at ₹120 crore
Updated On : 03 Mar 2026 | 4:28 PM IST

Swiggy hits all-time low; stock tanks 26% thus far in CY2026

The stock price of Swiggy slipped 5% and hit an all-time low of ₹285.85 on the BSE in Monday's intra-day, thus fell below its previous record low of ₹297 touched on May 13, 2025.

Swiggy hits all-time low; stock tanks 26% thus far in CY2026
Updated On : 02 Mar 2026 | 10:36 PM IST

Larsen & Toubro tanks 7%; stock records sharpest intra-day fall in 11 mths

Out of the international order book of ₹3.57 trillion, around 75 per cent is from the Middle East, L&T said in the Q3 earnings conference call on January 28, 2026.

Larsen & Toubro tanks 7%; stock records sharpest intra-day fall in 11 mths
Updated On : 02 Mar 2026 | 10:52 AM IST